Spanish gene therapy for Alzheimer's enters clinical trial phase

The first human trial of TET101, a gene therapy targeting Alzheimer's, begins in Spain.

Published 5h1 sourceNotable

≈ 18sSpeed

The fact

Developed by Álvaro Pascual-Leone, it aims to slow the disease's progression.

Preliminary results are expected by 2028, offering hope for early-stage patients.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on September 3, 2026